Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-23-038754)

Filing Details

Accession Number:: 0001209191-23-038754
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-06-21 16:05:17
Reporting Period:: 2023-06-16

Accepted Time:: 2023-06-21 16:05:17
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1654151	Deciphera Pharmaceuticals Inc.	DCPH	Pharmaceutical Preparations (2834)	200299725

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1752827	C. Daniel Martin	C/O Deciphera Pharmaceuticals, Inc. 200 Smith Street Waltham MA 02451	Chief Commercial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2023-06-16	1,238	$14.40	58,413	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

This sale was to cover tax liabilities in the vesting of restricted stock units.
Includes 1,270 shares acquired under the Issuer's 2017 Employee Stock Purchase Plan on May 14, 2023.